To determine a possible causal relationship, we performed in vitro functional studies showing that addition of recombinant YKL-40 proteins was sufficient to rescue Gi-coupled receptor signalling defect observed with primary osteoblasts derived from AIS patients. Here, CHI3L1 is linked to androgen insensitivity syndrome.